Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Reconstruction of larynx with epiglottis and strip muscular flap after extended partial laryngectomy with T3 category].

Zhonghua er bi yan hou ke za zhi·2000

Same author

Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemia.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2000

Same author

Development of an ELISA for paraquat; improvement of antibody characteristics by reversed affinity chromatography.

The Analyst·2000

Same author

Stepwise development of thymic microenvironments in vivo is regulated by thymocyte subsets.

Development (Cambridge, England)·2000

Same author

HIV-1 strains from a cohort of American subjects reveal the presence of a V2 region extension unique to slow progressors and non-progressors.

AIDS (London, England)·2000

Same author

[Expression of FADD in primary hepatocellular carcinoma and its relationship with hepatic apoptosis].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology·2000

Same journal

[Research progress on the impact of the digital information environment on the health of children and adolescents].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2026

Same journal

[Exploration and practice of ideological and political education integration in the "One Core, Two Integrations" curriculum model for epidemiology].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2026

Same journal

[Progress in research of visualization of ideology and politics elements in curriculum and its importance for <i>Epidemiology</i> curriculum].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2026

Same journal

[Operation of WeChat official accounts of <i>Chinese Journal of Epidemiology</i>].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2026

Same journal

[Study on the risk factors of development for mild cognitive impairment to Alzheimer's disease based on the competitive risk joint model].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2026

Same journal

[Mendelian randomization study on related factors for esophageal adenocarcinoma and Barrett's esophagus].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 8, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

[Progress in precision medicine: a scientific perspective].

B Wang¹, L M Li²

¹Health Science Popularization Research Center, Chinese Academy of Medical Sciences, Beijing 100730, China.

Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi

|January 20, 2017

Summary

This summary is machine-generated.

Precision medicine uses individual genetic, environmental, and lifestyle differences for personalized disease prevention and treatment. Despite criticisms, it holds promise as a future healthcare model.

Keywords:

Genomics Personalized medicine Precision medicine Precision prevention

More Related Videos

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Published on: December 1, 2023

Related Experiment Videos

Last Updated: Mar 8, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Published on: December 1, 2023

Area of Science:

Genomics and personalized healthcare

Background:

Precision medicine aims to tailor disease prevention and treatment to individual variability.
It considers genetics, environment, and lifestyle for precise classification and diagnosis.
Large-scale population cohort studies are crucial for advancing precision medicine.

Purpose of the Study:

To explore the foundational role of cohort studies in precision medicine.
To address current criticisms and future potential of precision medicine.

Main Methods:

Review of precision medicine strategies and their reliance on population cohort data.
Analysis of existing criticisms regarding patient benefit, health determinants, and resource allocation.

Main Results:

Precision medicine offers personalized, targeted prevention and treatment strategies.
Cohort studies provide essential evidence for precision medicine practices.
Criticisms include limited patient benefit, neglect of social determinants, and resource concerns.

Conclusions:

Precision medicine is a promising research area with the potential to revolutionize healthcare.
Despite challenges, it is expected to become a future healthcare practice model.